Insight

Stephen V Liu: Beautiful Review on Neoadjuvant Immunotherapy Across Tumor Types

Stephen V Liu/X

Jun 25, 2025, 23:31

Stephen V Liu: Beautiful Review on Neoadjuvant Immunotherapy Across Tumor Types

Stephen V Liu, Director of Thoracic Oncology and Associate Professor of Medicine at Georgetown University, shared a post on X:

“Beautiful review on neoadjuvant immunotherapy across tumor types and how we can further refine delivery and develop biomarkers, Nature Cancer.

Congratulations to Drs. Gil Awada, Tina Cascone, Michiel van der Heijden, Christian Blank, Marleen Kok, Myriam Chalabi.”

Title: The rapidly evolving paradigm of neoadjuvant immunotherapy across cancer types

Journal: Nature Cancer

Authors: Gil Awada, Tina Cascone, Michiel S. van der Heijden, Christian U. Blank, Marleen Kok, Myriam Chalabi

Read the full article.

Stephen V Liu: Beautiful Review on Neoadjuvant Immunotherapy Across Tumor Types

More posts featuring Stephen V Liu on OncoDaily.

cancer Christian Blank Christian U. Blank Georgetown University Gil Awada Marleen Kok Michiel S. Van der Heijden Michiel van der Heijden Myriam Chalabi OncoDaily Oncology Stephen V Liu Tina Cascone

Top GU Immunotherapy Trials to Watch at ESMO 2025

Hagop Kantarjian: Advances and Revolution in Adult ALL Therapy Over the Last Decade

FDA Priority Review Granted for TAR-200 After 82% Complete Response in BCG-Unresponsive Bladder Cancer

Top 10 Immunotherapy Fellowships and Grants to Watch in 2025

July Is Sarcoma Awareness Month: What You Need to Know